Eline van Beest

Eline van Beest serves as an Operating Partner at Thuja Capital, focusing on venture capital investments in (bio)pharmaceuticals, medtech, and digital health since January 2019. In June 2020, Eline became the Chief Executive Officer of Hybridize Therapeutics, a biotech firm specializing in RNA-based therapies for kidney diseases. Additional roles include Board Member and Treasurer at the Netherlands Academy of Engineering, Member of the Supervisory Board at LivAssured BV and YES!Delft, and Investment Committee member for multiple funds including Invest-NL, VGZ Voorop in Zorg Fonds, and Graduate Entrepreneur. Eline co-founded the Blue Sparrows MedTech Fund and has a solid educational background including an MSc in Strategic Product Design and an Executive Master of Business Innovation.